Tradohub B2B Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 05-11-2024
- Paid Up Capital ₹ 2.72 Cr
as on 05-11-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 19.15 Cr
as on 05-11-2024
- Satisfied Charges ₹ 10.00 Cr
as on 05-11-2024
- Revenue 189.85%
(FY 2018)
- Profit 349.85%
(FY 2018)
- Ebitda 395.39%
(FY 2018)
- Net Worth 714.74%
(FY 2018)
- Total Assets 230.49%
(FY 2018)
About Tradohub B2B
- CIN/LLPIN
U52512GJ2014PLC080207
- Company No.
080207
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2014
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
What products or services does Tradohub B2b Limited offer?
Tradohub B2B Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Flavours & Aromatics, Artificial Sweetener, Nutraceuticals & Dietary Supplements, Fitness Supplements, Medical Laboratory Instruments, VTM Kit Raw Materials, Nutritional Supplements, Pharma Ingredients & Raw Materials.
Who are the key members and board of directors at Tradohub B2B?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Akash Domadiya | Additional Director | 24-Jul-2014 | Current |
Keyur Shah | Additional Director | 07-Jan-2021 | Current |
Chandubhai Kalathiya | Additional Director | 07-Jan-2021 | Current |
Financial Performance of Tradohub B2B.
Tradohub B2B Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 189.85% increase. The company also saw a substantial improvement in profitability, with a 349.85% increase in profit. The company's net worth Soared by an impressive increase of 714.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Tradohub B2B?
In 2018, Tradohub B2B had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rajiv Ramanlal Trading Co. Private LimitedActive 17 years 11 months
Akash Domadiya is a mutual person
- Satark Real Estate Private LimitedActive 19 years 3 months
Keyur Shah and Chandubhai Kalathiya are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 27 Nov 2018 | ₹1.76 Cr | Open |
Others Creation Date: 16 Jul 2018 | ₹1.76 Cr | Open |
Others Creation Date: 29 May 2018 | ₹5.00 Cr | Open |
How Many Employees Work at Tradohub B2B?
Unlock and access historical data on people associated with Tradohub B2B, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tradohub B2B, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tradohub B2B's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.